Company Albireo Pharma, Inc. Deutsche Boerse AG
Equities
BDQM
US01345P1066
Biotechnology & Medical Research
Business Summary
Number of employees: 130
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ronald Cooper
CEO | Chief Executive Officer | 61 | 15-05-31 |
Founder | 60 | 03-12-07 | |
President | 57 | 23-03-01 | |
Joan Connolly
CTO | Chief Tech/Sci/R&D Officer | - | 21-04-12 |
Paul Streck
CTO | Chief Tech/Sci/R&D Officer | 60 | 22-12-18 |
Heather White
CTO | Chief Tech/Sci/R&D Officer | - | 23-03-01 |
Alan Sokaler
BRD | Director/Board Member | - | - |
Corporate Secretary | - | 23-03-01 | |
Michelle Graham
HRO | Human Resources Officer | 57 | 19-11-03 |
Muffy Carter
LAW | General Counsel | 71 | 16-11-28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 55 | 23-03-01 | |
Director/Board Member | 62 | 23-03-01 | |
Ronald Cooper
CEO | Chief Executive Officer | 61 | 15-05-31 |
Alan Sokaler
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 20,709,043 | 18,650,831 ( 90.06 %) | 7,760 ( 0.0375 %) | 90.06 % |
Company contact information
Albireo Pharma, Inc.
53 State Street 19th Floor
02109, Boston
+857 254 5555
Sector
1st Jan change | Capi. | |
---|---|---|
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |